MAP4K4 (Gene)

Synonyms:ENTREZ:9448, FLH21957, HEL-S-31, HGK, HGNC:6866, MAP4K4, MEKKK4, MIM:604666, NIK, NM_001242559, NM_001242560, NM_001384476, NM_001384477, NM_001384478, NM_001384481, NM_001384482, NM_001384483, NM_001384484, NM_001384485, NM_001384486, NM_001384487, NM_001384488, NM_001384490, NM_001384491, NM_001384492, NM_001384493, NM_001384494, NM_001384495, NM_001384496, NM_001384497, NM_001384506, NM_001384507, NM_001384508, NM_001384509, NM_001384520, NM_001384543, NM_001384548, NM_001384549, NM_001384550, NM_001384551, NM_001384552, NM_001384553, NM_001384554, NM_001384555, NM_001384556, NM_001384557, NM_001384558, NM_001384559, NM_001384560, NM_001384561, NM_001384562, NM_001384563, NM_001384564, NM_001384567, NM_001384572, NM_001384579, NM_004834, NM_145686, NM_145687, NP_001229488, NP_001229489, NP_001371405, NP_001371406, NP_001371407, NP_001371410, NP_001371411, NP_001371412, NP_001371413, NP_001371414, NP_001371415, NP_001371416, NP_001371417, NP_001371419, NP_001371420, NP_001371421, NP_001371422, NP_001371423, NP_001371424, NP_001371425, NP_001371426, NP_001371435, NP_001371436, NP_001371437, NP_001371438, NP_001371449, NP_001371472, NP_001371477, NP_001371478, NP_001371479, NP_001371480, NP_001371481, NP_001371482, NP_001371483, NP_001371484, NP_001371485, NP_001371486, NP_001371487, NP_001371488, NP_001371489, NP_001371490, NP_001371491, NP_001371492, NP_001371493, NP_001371496, NP_001371501, NP_001371508, NP_004825, NP_663719, NP_663720, NR_169279, NR_169280, NR_169281, NR_169282, XM_005264048, XM_005264050, XM_005264052, XM_005264057, XM_005264059, XM_005264060, XM_005264062, XM_005264063, XM_005264065, XM_005264066, XM_005264068, XM_005264069, XM_005264071, XM_006712865, XM_017005351, XM_017005354, XM_017005356, XM_017005357, XM_017005358, XM_017005360, XM_017005363, XM_017005366, XM_017005368, XM_017005369, XM_017005371, XM_017005372, XM_017005373, XP_005264105, XP_005264107, XP_005264109, XP_005264114, XP_005264116, XP_005264117, XP_005264119, XP_005264120, XP_005264122, XP_005264123, XP_005264125, XP_005264126, XP_005264128, XP_006712928, XP_016860840, XP_016860843, XP_016860845, XP_016860846, XP_016860847, XP_016860849, XP_016860852, XP_016860855, XP_016860857, XP_016860858, XP_016860860, XP_016860861, XP_016860862, mitogen-activated protein kinase kinase kinase kinase 4
Omim:OMIM:604666
Id:ENSG00000071054
Hgnc:HGNC:6866
Entrez:9448
Description:mitogen-activated protein kinase kinase kinase kinase 4
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View MAP4K4's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with MAP4K4.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using MAP4K4.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for MAP4K4.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with MAP4K4.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.